BridgeBio Pharma (BBIO) Current Deferred Revenue (2022 - 2026)
BridgeBio Pharma (BBIO) reported Current Deferred Revenue of $5.55 million for Q2 2026, down 47.4% from $10.54 million a year earlier and down 9.3% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Current Deferred Revenue (2022 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma posted Current Deferred Revenue of $7.19 million, down 50.8% from FY2024.
- Current Deferred Revenue has a three-year compound annual growth rate of -4.1% (FY2022 to FY2025).
- By year, Current Deferred Revenue came in at $14.6 million in FY2024 (+139.6%), $6.1 million in FY2023 (-25.3%) and $8.16 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q2 2022.
- Year over year, Current Deferred Revenue has now declined in each of the last six quarters, with growth averaging 0.4% over the last eight quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q2 2024 (growth of 143.1%); the low point was Q4 2025 (a decline of 50.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.12 million (Q1 2026), $7.19 million (Q4 2025) and $9.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | BridgeBio Pharma | 13.01 Bn | 10.12 Bn | 228.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.55 Mn |
| Mar 31, 2026 | 6.12 Mn |
| Dec 31, 2025 | 7.19 Mn |
| Sep 30, 2025 | 9.09 Mn |
| Jun 30, 2025 | 10.54 Mn |
| Mar 31, 2025 | 11.62 Mn |
| Dec 31, 2024 | 14.60 Mn |
| Sep 30, 2024 | 11.77 Mn |
| Jun 30, 2024 | 15.10 Mn |
| Mar 31, 2024 | 13.96 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 6.59 Mn |
| Jun 30, 2023 | 6.21 Mn |
| Mar 31, 2023 | 6.68 Mn |
| Dec 31, 2022 | 8.16 Mn |
| Sep 30, 2022 | 7.52 Mn |
| Jun 30, 2022 | 7.19 Mn |
API Access
BridgeBio Pharma Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();